Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 6:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 193–216 of 222 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Emotional Sensitivity test Clear all

Conditions: Lower Urinary Tract Symptoms
Interventions: None-observational, Magnetic Resonance Imaging (MRI), Multimodal Automated Sensory Testing System, Auditory Sensitivity Test; Other · Procedure
Lead sponsor: Arbor Research Collaborative for Health; Other
Eligibility: 18 Years and older
Enrollment: 1,879 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2015 – 2018
U.S. locations: 6
States / cities: Chicago, Illinois • Iowa City, Iowa • Ann Arbor, Michigan + 3 more

Conditions: Sciatic Nerve, Postural Lordosis, Nerve Pain
Interventions: Knee extension angle, Straight Leg Raise, Slump Test, Extended slump test; Diagnostic Test
Lead sponsor: University of Hartford; Other
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 1
States / cities: West Hartford, Connecticut

Conditions: Acute Coronary Syndrome
Interventions: Point of Care testing; Device
Lead sponsor: Integrated Medical Research LLC; Other
Eligibility: 35 Years and older
Enrollment: 705 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: MTBI - Mild Traumatic Brain Injury
Interventions: PATH + DigitMemory (DM) neurotraining; Behavioral
Lead sponsor: Perception Dynamics Institute; Industry
Eligibility: 18 Years to 60 Years
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 2
States / cities: San Diego, California • Solana Beach, California

Conditions: Central Visual Impairment, Macular Degeneration
Interventions: Condition 1: Training visual sensitivity, Condition 2: Training spatial integration, Condition 3: Training spatial attention, Condition 4: Combination training; Behavioral
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 18 Years to 30 Years
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 2
States / cities: Birmingham, Alabama • Riverside, California

Conditions: Spinal Cord Injury
Interventions: Not listed
Lead sponsor: University of Miami; Other
Eligibility: 18 Years to 65 Years
Enrollment: 27 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Miami, Florida

Conditions: Dementia, Caregiver, Emergency Department, Artificial Intelligence, Care Transition
Interventions: NeuViCare application; Other
Lead sponsor: Yale University; Other
Eligibility: 65 Years and older
Enrollment: 40 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Colorectal Cancer, Early Onset Colorectal Cancer, Diet Habit, Risk Reduction
Interventions: Semi Quantitative Food Frequency Questionnaire (SQFFQ); Behavioral
Lead sponsor: San Raffaele University; Other
Eligibility: 18 Years to 49 Years
Enrollment: 2,300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2035
U.S. locations: 2
States / cities: Denver, Colorado • Chicago, Illinois

Conditions: Polycystic Ovary Syndrome, PCOS
Interventions: Frequently Sampled Intravenous Glucose Tolerance Test (FSIVGTT); Other
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 12 Years to 18 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: Treatment Resistant Depression
Interventions: Tianeptine Sodium; Drug
Lead sponsor: Jonathan A. Javitch, MD, PhD; Other
Eligibility: 21 Years to 60 Years
Enrollment: 38 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 3
States / cities: Stanford, California • New York, New York

Conditions: Pre-diabetes
Interventions: Behavioral: exercise; Other
Lead sponsor: Pennington Biomedical Research Center; Other
Eligibility: 30 Years to 60 Years · Male only
Enrollment: 42 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2012
U.S. locations: 1
States / cities: Baton Rouge, Louisiana

Conditions: High Risk Pregnancy
Interventions: MRI, MRI - IUGR; Device
Lead sponsor: Oregon Health and Science University; Other
Eligibility: 18 Years to 52 Years · Female only
Enrollment: 379 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 2
States / cities: Portland, Oregon • Salt Lake City, Utah

Conditions: Dentin Sensitivity
Interventions: Stannous fluoride toothpaste, Crest cavity protection toothpaste; Drug
Lead sponsor: HALEON; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024
U.S. locations: 1
States / cities: Fort Wayne, Indiana

Conditions: Pancreas Adenocarcinoma, Dysplasia
Interventions: LINFU™; Diagnostic Test
Lead sponsor: Adenocyte, LLC; Industry
Eligibility: 18 Years to 90 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Sarasota, Florida

Conditions: Deep Vein Thrombosis, Pulmonary Embolism
Interventions: Magnetic Resonance Imaging, Bicycle Ergometry, Lab Panel, Questionnaires; Other · Behavioral
Lead sponsor: University of Texas Southwestern Medical Center; Other
Eligibility: 8 Years to 21 Years
Enrollment: 5 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2022
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8, Anatomic Stage IIA Breast Cancer AJCC v8, Anatomic Stage IIB Breast Cancer AJCC v8, Anatomic Stage III Breast Cancer AJCC v8, Anatomic Stage IIIA Breast Cancer AJCC v8, Anatomic Stage IIIB Breast Cancer AJCC v8, Anatomic Stage IIIC Breast Cancer AJCC v8, Anatomic Stage IV Breast Cancer AJCC v8, Invasive Breast Carcinoma, Prognostic Stage I Breast Cancer AJCC v8, Prognostic Stage IA Breast Cancer AJCC v8, Prognostic Stage IB Breast Cancer AJCC v8, Prognostic Stage II Breast Cancer AJCC v8, Prognostic Stage IIA Breast Cancer AJCC v8, Prognostic Stage IIB Breast Cancer AJCC v8, Prognostic Stage III Breast Cancer AJCC v8, Prognostic Stage IIIA Breast Cancer AJCC v8, Prognostic Stage IIIB Breast Cancer AJCC v8, Prognostic Stage IIIC Breast Cancer AJCC v8, Prognostic Stage IV Breast Cancer AJCC v8
Interventions: Biopsy, Conventional Surgery, Genetic Testing; Procedure · Other
Lead sponsor: M.D. Anderson Cancer Center; Other
Eligibility: 18 Years and older · Female only
Enrollment: 1,100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2026
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Colorectal Cancer
Interventions: Blood Draw; Other
Lead sponsor: Clinical Genomics Pathology; Industry
Eligibility: 18 Years and older
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 6
States / cities: Redondo Beach, California • Tampa, Florida • Chicago, Illinois + 3 more

Conditions: Abdominal Aortic Aneurysm (AAA), No Abdominal Aortic Aneurysm (Non-AAA)
Interventions: AAA Group (Aim 3A), Non-AAA Group, Ex Vivo Human AAA Specimens (Aim 2A), Relationship between radiotracer and CCR2 (Aim 2B), AAA Group (Aim 3B-Reproducibility); Diagnostic Test · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 40 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Allergy, Allergic Asthma, Allergy to Cats, Allergy to House Dust, Allergy to Dog Dander, Allergy Cockroach
Interventions: Blood Collection; Device
Lead sponsor: Abionic SA; Industry
Eligibility: 6 Years and older
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 5
States / cities: Washington D.C., District of Columbia • Baltimore, Maryland • Crownsville, Maryland + 1 more

Conditions: Pulmonary Vascular Disease
Interventions: GE-141, Hyperpolarized 129Xenon gas, MRI; Drug · Device
Lead sponsor: Bastiaan Driehuys; Other
Eligibility: 18 Years and older
Enrollment: 62 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2020
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Genital Herpes
Interventions: Not listed
Lead sponsor: Centers for Disease Control and Prevention; Federal
Eligibility: 16 Years to 55 Years
Enrollment: 2,500 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2011
U.S. locations: 3
States / cities: Baltimore, Maryland • Boston, Massachusetts • New York, New York

Conditions: Prediabetes, Vitamin D Deficiency
Interventions: Cholecalciferol (vitamin D3); Dietary Supplement
Lead sponsor: University of Minnesota; Other
Eligibility: 18 Years to 65 Years
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Obesity, Insulin Resistance
Interventions: Not listed
Lead sponsor: Yale University; Other
Eligibility: 12 Years to 17 Years
Enrollment: 51 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2017
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Breast Cancer
Interventions: Exercise Recall Patient Reported Outcomes, Health Behavior Questionnaire (HBQ)30 Patient Reported Outcomes, Functional Assessment of Cancer Therapy-General (FACT-G) Patient Reported Outcomes, Functional Assessment of Chronic Illness Therapy-Fatigue (FACIT-F) Patient Reported Outcomes, Patient Reported Outcomes PROMIS Cognitive Function (Short Form 8a), Patient Reported Outcomes Functional Assessment of Cancer-Gynecology Oncology Group-Neurotoxicity (FACT/GOG-NTX-12), Patient Reported Outcomes PROMIS, Patient Reported Outcomes FACT-Endocrine Symptoms, Patient Reported Outcomes Penn Arthralgia Aging Survey, Patient Reported Outcomes PRO-CTCAE (patient-reported CTCAE), p16 tumor suppressor gene; Behavioral · Diagnostic Test
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 21 Years and older · Female only
Enrollment: 253 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Search by objective public record fields.

Symptoms of Lower Urinary Tract Dysfunction Phenotyping Study

Spine Position and Neural Sensitivity

Improving the Management of Acute Coronary Syndromes in the Emergency Department

Retraining Neural Pathways Improves Cognitive Skills After A Mild Traumatic Brain Injury

Factors in Learning And Plasticity: Healthy Vision

6 Minute Propulsion Test Sensitivity to Increased Aerobic Capacity

Artificial Intelligence + Care Coach Intervention

Exogenous and Endogenous Risk Factors for Early-onset Colorectal Cancer

Insulin Differences Between African-American and Caucasian Female Adolescents With Polycystic Ovary Syndrome (PCOS)

Tianeptine for Treatment Resistant Depression

The Insulin Sensitivity Using Aerobic Interval Conditioning

Placenta Imaging Project

Clinical Study to Evaluate the Anti-sensitivity Efficacy of a Stannous Fluoride Toothpaste in a Population of Dentin Hypersensitivity Sufferers

A Proof-of-Concept Study Evaluating LINFU™

Exercise Intolerance and Skeletal Muscle Bioenergetics in Children With Deep Venous Thrombosis

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Paired Analysis of Sensitivity for Colorectal Cancer Using COLVERA : PASCAL

NIH CCR2 AAA Study

abioSCOPE IgE Assay to Aid in the Diagnosis of Allergies

Non-Invasive Diagnosis of Pulmonary Vascular Disease Using Inhaled 129Xe Magnetic Resonance Imaging

Serologic Assays for the Diagnosis of Herpes Simplex Virus Type 2

Effect of Vitamin D Deficiency and Vitamin D Supplementation on Glucose Metabolism

Neural Functioning of Feeding Centers in Obese Youth

Long-Term Follow-Up in Women With Early Breast Cancer Three Years of More Post Primary Treatment